AChild - Austrian Children With Hearing Impairment - Longitudinal Database

NCT ID: NCT04317456

Last Updated: 2022-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-01

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is high variability in outcomes in children with hearing impairment. Existing literature focus mainly on subpopulations (children with hearing aids, children with CI) and is usually not epidemiological. Often children with additional needs (intellectual disability, visual impairment, autism spectrum disorder, complex syndromes) are excluded from the studies. This subgroup of children makes up around 1/3 of the population of children with hearing impairment.

What factors contribute to the unexplained variance in language development in children with hearing loss? (including children with additional needs, multilingual) There is a lack of European epidemiological studies that evaluate the effects of Newborn Hearing Screening and early intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aims:

* to collect population based data on children born in Upper Austria with a significant hearing impairment and to describe this population in detail regarding audiological, etiological (including geno- and phenotypical correlations), neurodevelopmentally, psychological, psychiatrically and linguistically with a special interest is in children with additional needs
* collecting child development outcomes (language, communication, psychosocial) and family outcomes (quality of life, stress)
* to investigate possible effects of the Newborn Hearing Screening, early intervention and specific parent behaviors targeted in early intervention
* collecting developmental trajectories of the total sample and subgroups of the sample (particularly audiological, etiological and cognitive). This data should help identify red flags
* investigating predictors of developmental trajectories regarding the child and the intervention (e.g. time and

Hypothesis:

* It is expected that .2% of the total population of preschool children have a sensorineural hearing loss (bilateral and unilateral)
* a significantly higher prevalence of intellectual disabilities (up to 20%), visual impairment, autism spectrum disorder and motor impairment
* it is expected that for at least 50% of the children, there is a genetic explanation for the hearing impairment and 30% out of them are expected to be syndromal
* it is expected that there is a higher proportion of children with psycho-social problems (especially peer problems and behavioral-/emotional problems)
* Due to a change in the environmental conditions over the past two decades, better child outcomes, compared to previous ones are expected. Nevertheless around 30-50% of the children are expected to not be reaching their nonverbal cognitive potential.
* expected intervention effects, particularly for provision with and use of hearing technology family-child interaction self-efficacy and wellbeing of the family regulated media use

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Impaired Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hearing Aids and Hearing Implants

Hearing Aids and Hearing Implants (age at first fitting and implantation and aided audibility)

Intervention Type DEVICE

Family Centred Early Intervention

Family Centred Early Intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* with significant sensorineural hearing impairment or permanent congenital conductive deafness; profound hearing impairment above frequency of 0.5, 1, 2 and 4 kHz of ≥ 25 dB
* unilateral or bilateral
* diagnosed before the age of 6 years
* including children with multiple disabilities
* including children with another language than German (including sign language)
* including children with auditory neuropathy spectrum disorder (ANS)
* including children with behavioral problems and psychiatric disorders

Exclusion Criteria

* children who were older than 6 years when they were diagnosed
* who's families do not agree to participate in the study
* with temporary conductive deafness
Maximum Eligible Age

72 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johannes Kepler University of Linz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Johannes Kepler University

Linz, , Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Daniel Holzinger, PhD

Role: CONTACT

00437327897 ext. 13720

Magdalena Dall, MSc

Role: CONTACT

0043664602468641

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Daniel Holzinger, PhD

Role: primary

00437327897 ext. 13720

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AChild

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.